×
About 3,520 results

ALLMedicine™ Liver Transplants Center

Research & Reviews  1,525 results

Liver Metastasis Irradiation Can Restore Immunotherapeutic Responsiveness.
https://doi.org/10.1016/j.it.2021.02.007
Trends in Immunology; Demaria S, Formenti SC

Feb 27th, 2021 - Allogeneic liver transplants tolerize the immune system, preventing organ rejection from the same donor. A recent article by Yu et al. shows that liver metastases can likewise prevent tumor rejection in immunotherapy-treated murine and human hosts...

Recipient gender and body mass index are associated with early acute rejection in donat...
https://doi.org/10.1016/j.clirex.2020.100004
Clinics and Research in Hepatology and Gastroenterology; Wei Q, Wang K et. al.

Feb 19th, 2021 - Early acute rejection (EAR) is a common complication after liver transplantation (LT). The aim of this study was to evaluate the incidence and risk factors of EAR in donation after cardiac death (DCD) liver transplantation recipients. We retrospec...

OPTN/SRTR 2019 Annual Data Report: Liver.
https://doi.org/10.1111/ajt.16494
American Journal of Transplantation : Official Journal Of... Kwong AJ, Kim WR et. al.

Feb 17th, 2021 - This year was notable for changes to exception points determined by the geographic median allocation Model for End-Stage Liver Disease (MELD) and implementation of the National Liver Review Board, which took place on May 14, 2019. The national acu...

Delayed kidney transplantation in combined liver-kidney transplantation.
https://doi.org/10.1097/MOT.0000000000000858
Current Opinion in Organ Transplantation; Ekser B, Goggins WC

Feb 17th, 2021 - To review the impact of delayed kidney transplantation approach in combined (simultaneous) liver-kidney transplantation (CLKT). CLKT offers a life-saving procedure for patients with both end-stage liver disease and chronic kidney disease or prolon...

see more →

Guidelines  1 results

Evaluation for Liver Transplantation in Adults: 2013 Practice Guideline by the AASLD and the...
https://www.aasld.org/sites/default/files/guideline_documents/141020_Guideline_Evaluation_Adult_LT_4UFb_2015.pdf
Paul Martin

Dec 31st, 2012 - Liver disease is the twelfth commonest cause of mortality in adults in the United States, resulting in 34,000 deaths annually from cirrhosis. 7 In addition, the rising incidence of HCC in the United States is reflected in an increasing number of de.

see more →

Drugs  95 results see all →

Clinicaltrials.gov  1,755 results

Liver Metastasis Irradiation Can Restore Immunotherapeutic Responsiveness.
https://doi.org/10.1016/j.it.2021.02.007
Trends in Immunology; Demaria S, Formenti SC

Feb 27th, 2021 - Allogeneic liver transplants tolerize the immune system, preventing organ rejection from the same donor. A recent article by Yu et al. shows that liver metastases can likewise prevent tumor rejection in immunotherapy-treated murine and human hosts...

Recipient gender and body mass index are associated with early acute rejection in donat...
https://doi.org/10.1016/j.clirex.2020.100004
Clinics and Research in Hepatology and Gastroenterology; Wei Q, Wang K et. al.

Feb 19th, 2021 - Early acute rejection (EAR) is a common complication after liver transplantation (LT). The aim of this study was to evaluate the incidence and risk factors of EAR in donation after cardiac death (DCD) liver transplantation recipients. We retrospec...

OPTN/SRTR 2019 Annual Data Report: Liver.
https://doi.org/10.1111/ajt.16494
American Journal of Transplantation : Official Journal Of... Kwong AJ, Kim WR et. al.

Feb 17th, 2021 - This year was notable for changes to exception points determined by the geographic median allocation Model for End-Stage Liver Disease (MELD) and implementation of the National Liver Review Board, which took place on May 14, 2019. The national acu...

Delayed kidney transplantation in combined liver-kidney transplantation.
https://doi.org/10.1097/MOT.0000000000000858
Current Opinion in Organ Transplantation; Ekser B, Goggins WC

Feb 17th, 2021 - To review the impact of delayed kidney transplantation approach in combined (simultaneous) liver-kidney transplantation (CLKT). CLKT offers a life-saving procedure for patients with both end-stage liver disease and chronic kidney disease or prolon...

see more →

News  139 results

Liver Disease Common After Fontan Procedure
https://www.medscape.com/viewarticle/935958

Aug 19th, 2020 - NEW YORK (Reuters Health) - Most patients will develop liver fibrosis after their Fontan procedure, and many will require heart-liver transplants, according to a new review. "Fontan-associated liver disease (FALD) is underdiagnosed," Dr. Juliet Em...

'Striking' Drop in Organ Transplants Seen With COVID-19 Pandemic
https://www.staging.medscape.com/viewarticle/930348

May 11th, 2020 - NEW YORK (Reuters Health) - The COVID-19 pandemic has led to a sharp drop in organ transplantation in the United States and France, a new report in The Lancet shows. From late February to early April, deceased donor transplantations fell by 51.1% ...

AASLD: Liver transplants should proceed despite COVID-19
https://www.mdedge.com/gihepnews/article/220026/coronavirus-updates/aasld-liver-transplants-should-proceed-despite-covid-19?channel=63993
M. Alexander Otto, MDedge News

Apr 1st, 2020 - In liver transplant recipients or patients with autoimmune hepatitis on immunosuppressive therapy, acute cellular rejection or disease flare should not be presumed in the face of active coronavirus disease 2019 (COVID-19), according to the America.

Gilead's NASH combination treatment fails mid-stage study
https://www.reuters.com/article/us-gilead-sciences-nash/gileads-nash-combination-treatment-fails-mid-stage-study-idUSKBN1YK18S

Dec 16th, 2019 - (Reuters) - Gilead Sciences Inc said on Monday all combinations of its three drugs to treat NASH were unsuccessful in a mid-stage study, the latest failure in a string of trials seeking to develop the first approved treatment for the fatty liver d...

Study links hepatitis, higher mortality post liver transplant
https://www.mdedge.com/jcomjournal/article/211752/hepatology/study-links-hepatitis-higher-mortality-post-liver-transplant?channel=302
Richard Mark Kirkner

Nov 6th, 2019 - Liver transplant for the three predominant autoimmune liver diseases – primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis – has been known to have favorable outcomes overall, but little evidence comparing cholang.

see more →

Patient Education  5 results see all →